Structure and flexibility of the yeast NuA4 histone acetyltransferase complex

  1. Stefan A Zukin
  2. Matthew R Marunde
  3. Irina K Popova
  4. Katarzyna M Soczek
  5. Eva Nogales  Is a corresponding author
  6. Avinash B Patel  Is a corresponding author
  1. Harvard University, United States
  2. EpiCypher, United States
  3. University of California, Berkeley, United States
  4. Lawrence Berkeley National Laboratory, United States
  5. Northwestern University, United States

Abstract

The NuA4 protein complex acetylates histones H4 and H2A to activate both transcription and DNA repair. We report the 3.1 Å-resolution cryo-electron microscopy structure of the central hub of NuA4, which flexibly tethers the HAT and TINTIN modules. The hub contains the large Tra1 subunit and a core that includes Swc4, Arp4, Act1, Eaf1 and the C-terminal region of Epl1. Eaf1 stands out as the primary scaffolding factor that interacts with the Tra1, Swc4 and Epl1 subunits and contributes the conserved HSA helix to the Arp module. Using nucleosome binding assays, we find that the HAT module, which is anchored to the core through Epl1, recognizes H3K4me3 nucleosomes with hyperacetylated H3 tails, while the TINTIN module, anchored to the core via Eaf1, recognizes nucleosomes that have hyperacetylated H2A and H4 tails. Together with the known interaction of Tra1 with site-specific transcription factors, our data suggests a model in which Tra1 recruits NuA4 to specific genomic sites then allowing the flexible HAT and TINTIN modules to select nearby nucleosomes for acetylation.

Data availability

The cryo-EM maps and coordinate models have been deposited in the Electron Microscopy Data Bank with the accession codes EMD-28575 (NuA4 full), EMD-28563 (NuA4 core), EMD-28565 (NuA4 Tra1-FATKIN), EMD-28566 (Tra1-HEAT), EMD-28568 (Tra1-HEAT-top), EMD-28569 (Tra1-HEAT-middle), EMD-28567 (Tra1-HEAT-bottom) and in the Protein Data Bank with the accession codes PDB-8ESC (NuA4). Plasmids for HAT and TINTIN expression have been made available through Addgene (Catalog #193325 (S.c. NuA4 HAT) and #193326 (S.c NuA4 TINTIN)).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Stefan A Zukin

    Department of Genetics, Harvard University, Boston, United States
    Competing interests
    No competing interests declared.
  2. Matthew R Marunde

    EpiCypher, Durham, United States
    Competing interests
    Matthew R Marunde, EpiCypher is a commercial developer and supplier of reagents (e.g. PTM-defined semi-synthetic nucleosomes; dNucs) and platforms (dCypher®) used in this study..
  3. Irina K Popova

    EpiCypher, Durham, United States
    Competing interests
    Irina K Popova, EpiCypher is a commercial developer and supplier of reagents (e.g. PTM-defined semi-synthetic nucleosomes; dNucs) and platforms (dCypher®) used in this study..
  4. Katarzyna M Soczek

    California Institute for Quantitative Biology, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  5. Eva Nogales

    Molecular Biophysics and Integrative Bio-Imaging Division, Lawrence Berkeley National Laboratory, Berkeley, United States
    For correspondence
    enogales@lbl.gov
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9816-3681
  6. Avinash B Patel

    Molecular Biosciences, Northwestern University, Evanston, United States
    For correspondence
    avinash.patel@northwestern.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9140-8375

Funding

National Institute of General Medical Sciences (R35-GM127018)

  • Stefan A Zukin
  • Eva Nogales
  • Avinash B Patel

National Institute of General Medical Sciences (R44GM117683)

  • Matthew R Marunde
  • Irina K Popova

National Institute of General Medical Sciences (R44GM116584)

  • Matthew R Marunde
  • Irina K Popova

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,386
    views
  • 312
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Stefan A Zukin
  2. Matthew R Marunde
  3. Irina K Popova
  4. Katarzyna M Soczek
  5. Eva Nogales
  6. Avinash B Patel
(2022)
Structure and flexibility of the yeast NuA4 histone acetyltransferase complex
eLife 11:e81400.
https://doi.org/10.7554/eLife.81400

Share this article

https://doi.org/10.7554/eLife.81400

Further reading

    1. Structural Biology and Molecular Biophysics
    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.

    1. Structural Biology and Molecular Biophysics
    Yuanyuan Wang, Fan Xu ... Yongning He
    Research Article

    SCARF1 (scavenger receptor class F member 1, SREC-1 or SR-F1) is a type I transmembrane protein that recognizes multiple endogenous and exogenous ligands such as modified low-density lipoproteins (LDLs) and is important for maintaining homeostasis and immunity. But the structural information and the mechanisms of ligand recognition of SCARF1 are largely unavailable. Here, we solve the crystal structures of the N-terminal fragments of human SCARF1, which show that SCARF1 forms homodimers and its epidermal growth factor (EGF)-like domains adopt a long-curved conformation. Then, we examine the interactions of SCARF1 with lipoproteins and are able to identify a region on SCARF1 for recognizing modified LDLs. The mutagenesis data show that the positively charged residues in the region are crucial for the interaction of SCARF1 with modified LDLs, which is confirmed by making chimeric molecules of SCARF1 and SCARF2. In addition, teichoic acids, a cell wall polymer expressed on the surface of gram-positive bacteria, are able to inhibit the interactions of modified LDLs with SCARF1, suggesting the ligand binding sites of SCARF1 might be shared for some of its scavenging targets. Overall, these results provide mechanistic insights into SCARF1 and its interactions with the ligands, which are important for understanding its physiological roles in homeostasis and the related diseases.